Mutual Of America Capital Management LLC Global Blood Therapeutics, Inc. Transaction History

Mutual Of America Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $2.48 Million - $3.5 Million	-46,928 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$48.73 - $81.82 $154,766 - $259,860	-3,176 Reduced 6.34%	46,928 $2.96 Million
Q1 2020 May 11, 2020	SELL	$41.72 - $87.2 $91,867 - $192,014	-2,202 Reduced 4.21%	50,104 $2.56 Million
Q4 2019 Feb 11, 2020	BUY	$45.7 - $81.86 $838,732 - $1.5 Million	18,353 Added 54.05%	52,306 $4.16 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $8,571 - $10,944	-189 Reduced 0.55%	33,953 $1.65 Million
Q2 2019 Aug 12, 2019	BUY	$52.6 - $63.29 $296,769 - $357,082	5,642 Added 19.8%	34,142 $1.8 Million
Q1 2019 May 13, 2019	BUY	$39.99 - $53.48 $1.14 Million - $1.52 Million	28,500 New	28,500 $1.51 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.